Jupiter Life Line Hospitals JLHL
Western India multi-specialty chain (Thane, Pune, Indore, Dombivli) focused on tertiary and quaternary care
Mapped in 1 theme: Hospitals & Healthcare.
Where Jupiter Life Line Hospitals sits in the supply chain
Jupiter Life Line Hospitals appears in 1 supply-chain layer in one theme, Hospitals & Healthcare.
Hospitals & Healthcare › Multi-specialty hospital chains
OperatorOther companies in this layer
Revenue and profit
| ₹ Cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 733 | 893 | 1,073 | 1,302 | 1,500 |
| Net profit | 51 | 73 | 177 | 194 | 194 |
Latest-year revenue ₹1,500 Cr (FY26, company-wide).
Strengths
- Mature Thane and Pune hospitals with high occupancy
- Net-cash balance sheet after the 2023 IPO funds new hospitals
- Focused on high-acuity specialties in a well-insured catchment
Risks
- Small network - each new hospital is a large share of earnings
- New Dombivli and Pune capacity dilutes margins while ramping up
- Competition from larger chains entering Mumbai and Pune
Common questions
What does Jupiter Life Line Hospitals do?
Western India multi-specialty chain (Thane, Pune, Indore, Dombivli) focused on tertiary and quaternary care.
Where does Jupiter Life Line Hospitals sit in the supply chain?
Jupiter Life Line Hospitals (NSE: JLHL) is mapped in 1 supply-chain layer: Multi-specialty hospital chains (Hospitals & Healthcare).
Who are Jupiter Life Line Hospitals' peers?
In the Multi-specialty hospital chains layer of Hospitals & Healthcare: Apollo Hospitals Enterprise, Max Healthcare Institute, Manipal Health Enterprises (Manipal Hospitals), Fortis Healthcare, Global Health (Medanta), Narayana Hrudayalaya (Narayana Health) and 5 more.
What is Jupiter Life Line Hospitals' market cap and valuation?
As of 6 Nov 2026: market cap ₹9,438 Cr, P/E 49.7x, ROCE 14.8%, ROE 13.1%, dividend yield 0.07%.